GlassScriptPhysician profile
Scott G Darby
NPI 1063851996
$1,291.23
in general payments reported to CMS, 2019-2025
18 companies · $192 in 2025
The $192 reported for 2025 was more than what a typical Pediatrics provider received nationally (typical 2025 total: $96.93).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $127 · 2020: $33.47 · 2021: $28.68 · 2022: $224 · 2023: $294 · 2024: $392 · 2025: $192.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $878.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $877.81 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Supernus Pharmaceuticals, INC. | $354.46 | 2023-2025 | Qelbree, Qelbree |
| Merck Sharp & Dohme LLC | $174.51 | 2019-2025 | Vaxelis, Gardasil 9, Vaxneuvance |
| Corium, LLC | $161.22 | 2022-2025 | Azstarys |
| Sobi, INC | $95.91 | 2022-2023 | |
| Kaleo, INC. | $81.08 | 2019-2023 | Auvi-Q |
| Pfizer INC. | $68.14 | 2019-2025 | |
| Sanofi-Aventis U.S. LLC | $64.13 | 2024-2025 | |
| Ironshore Pharmaceuticals INC. | $48.41 | 2019-2020 | |
| Alk-Abello, INC | $33.01 | 2025 | Neffy, Odactra, Grastek |
| Cranial Technologies, INC | $31.17 | 2023-2024 | Doc Band |
| Tris Pharma INC | $28.24 | 2019-2020 | |
| Glaxosmithkline, LLC. | $27.38 | 2019-2022 | |
| Ars Pharmaceuticals Operations, INC. | $27.00 | 2025 | Neffy |
| Genzyme Corporation | $26.06 | 2024 | |
| Takeda Pharmaceuticals U.S.A., INC. | $20.83 | 2022 |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Sanofi Pasteur INC. | $17.37 | 2023 | |
| Neos Therapeutics, LP | $17.22 | 2024 | Adzenys Xr-Odt |
| Novartis Pharmaceuticals Corporation | $15.09 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Scott Darby listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.